BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (NASDAQ:CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023.
Details are as follows:
Citi's 18th Annual BioPharma Conference
Location: Boston, MA
Format: 1x1 Meetings
Date: Thursday, September 7
H.C. Wainwright 25th Annual Global Investment Conference
Location: New York, NY
Format: Presentation
Date: Monday, September 11
Time: 4:00 PM ET